Allogene Therapeutics, Inc. Liquidation Value
ALLO
Other
Cash & Equivalents
$51.69M
As of 2025-12-31
Current Price: $2.35 (as of 2026-04-24)
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $51.69M
Total Obligations: -$115.77M
$-64.08M
Per share: $-0.28
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $51.69M
AR: $0
Total Obligations: -$115.77M
$-64.08M
Per share: $-0.28
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $51.69M
AR: $0
Inventory: $0
Total Obligations: -$115.77M
$-64.08M
Per share: $-0.28
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-64.08M | $-0.28 |
| Liquid Liquidation Value | $-64.08M | $-0.28 |
| Operating Liquidation Value | $-64.08M | $-0.28 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $51.69M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $32.51M |
| Long-term Debt | N/A |
| Op. Lease Liability | $83.25M |
| Finance Lease | N/A |
| Shares Outstanding | 229.4M |
Explore all 169 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $51.69M | N/A | N/A | $4.27M | $32.51M | N/A | $83.25M | N/A |
| 2025-09-30 | $37.81M | N/A | N/A | $3.70M | $31.83M | N/A | $85.14M | N/A |
| 2025-06-30 | $52.33M | N/A | N/A | $4.85M | $31.68M | N/A | $87.00M | N/A |
| 2025-03-31 | $42.45M | N/A | N/A | $5.06M | $30.02M | N/A | $88.92M | N/A |
| 2024-12-31 | $75.22M | N/A | N/A | $5.39M | $35.52M | N/A | $90.76M | N/A |
| 2024-09-30 | $51.24M | N/A | N/A | $5.51M | $32.57M | N/A | $92.52M | N/A |
| 2024-06-30 | $170.67M | N/A | N/A | $12.94M | $37.30M | N/A | $94.21M | N/A |
| 2024-03-31 | $51.04M | N/A | N/A | $5.78M | $30.89M | N/A | $95.85M | N/A |
▼ Community Notes